Not available
Quote | Unity Biotechnology Inc. (NASDAQ:UBX)
Last: | $1.51 |
---|---|
Change Percent: | -1.95% |
Open: | $1.57 |
Close: | $1.54 |
High: | $1.57 |
Low: | $1.49 |
Volume: | 61,266 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Unity Biotechnology Inc. (NASDAQ:UBX)
2024-05-14 17:26:10 ET More on Unity Biotechnology Seeking Alpha’s Quant Rating on Unity Biotechnology Historical earnings data for Unity Biotechnology Financial information for Unity Biotechnology Read the full article on Seeking Alpha For fur...
SOUTH SAN FRANCISCO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2024. "Our team r...
Message Board Posts | Unity Biotechnology Inc. (NASDAQ:UBX)
Subject | By | Source | When |
---|---|---|---|
Ther meme stock..good news | Jayzp | investorshub | 04/21/2023 2:45:03 PM |
Wedge forming | MedicallyApproved658 | investorshub | 04/20/2023 7:32:52 PM |
I also did, but now I am and | surfkast | investorshub | 04/18/2023 4:44:00 PM |
Made money $UBX$..now back on the watch list, gl... | Pisd | investorshub | 04/18/2023 1:44:56 PM |
Until they have a success, temporary moves up | surfkast | investorshub | 04/17/2023 4:04:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Unity Biotechnology Inc. Company Name:
UBX Stock Symbol:
NASDAQ Market:
Unity Biotechnology Inc. Website:
SOUTH SAN FRANCISCO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2024. "Our team r...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at t...
SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the ongoing Phase 2b ASPIRE study of UBX1325 has been e...